Volcano Corp. (VOLC) is in the Health Care Industry

• Sort by

• Volcano Corporation Q3 2008 Earnings Call Transcript

  Question-and-Answer SessionOperator Operator instructions. We'll take our first question from Mike Weinstein with JP Morgan. Mike Weinstein – JP Morgan Thanks. Good afternoon, guys. John Dahldorf Hi, Mike. Mike Weinstein – JP Morgan Hi, there. Let me start with a couple items. First, I would hope that you could...

  Earnings calls 2008-11-24

  Tags: U.S., J.P. Morgan Chase & Co., Call Transcript, Earnings, Sales Strategy, Healthcare, Federal Government, Sales Force Management, Sales, Government, Seeking Alpha, Volcano Corp.

• Volcano Corporation Q2 2008 Earnings Call Transcript

  Question-and-Answer Session Operator Thank you. Operator instructions We'll go first to Michael Weinstein with JP Morgan. Michael Weinstein – JP Morgan Good afternoon, guys. Nice quarter. Let me ask you just a couple of items, just on a better read on, you obviously had a very strong...

  Earnings calls 2008-09-05

  Tags: Volcano Corp.

• Volcano Corporation, Q1 2008 Earnings Call Transcript

  Question-and-Answer SessionOperator Operator Instruction. And we will hear first from Michael Weinstein with J.P. Morgan. Chris Rogers Hi guys this is Chris Rogers calling here for Mike. Couple of questions Mike, couple of questions. First, Scott, can you expand on the type of deal you are...

  Earnings calls 2008-05-07

  Tags: Volcano Corp.

• Volcano Corporation Q4 2007 Earnings Call Transcript

  Question-and-Answer SessionOperator Thank you Operator Instructions We'll hear first from Mike Weinstein with J.P. Morgan. Mike Weinstein - J.P. Morgan Thanks. Good evening, guys. John Dahldorf Hi, Mike. Mike Weinstein - J.P. Morgan Hi, John. Nice quarter, and maybe I just want to dive into it. First a little...

  Earnings calls 2008-02-12

  Tags: Volcano Corp.

Additional Resources

• Volcano Corporation Presentation at Piper Jaffray Conference to Be Webcast

  SAN DIEGO, Nov. 24 /PRNewswire-FirstCall/ -- Volcano Corporation , a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, said today that it will be participating in the 20th Annual Piper Jaffray Health Care Conference on Tuesday, December...

  Articles 2008-11-24

• Volcano Reports 40 Percent Growth in Quarterly Revenues

  Growth Driven by 78 Percent Increase in IVUS System Sales SAN DIEGO, Calif., Nov. 5 /PRNewswire-FirstCall/ -- Volcano Corporation , a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, today reported that revenues for the...

  Articles 2008-11-05

• Volcano Corporation Schedules Third Quarter Conference Call, Webcast

  SAN DIEGO, Oct. 28 /PRNewswire-FirstCall/ -- Volcano Corporation , a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, today announced that it will report its operating results for the third quarter and first nine months of fiscal...

  Articles 2008-10-28

• Volcano Corporation Announces Launch of PrimeWire™ Pressure Guidewire and s5-FFR Option for Existing Fleet of s5 IVUS Consoles

  FAME Data Demonstrates 30% Reduction in Composite Events When Using Routine FFR Guidance in Multi-Vessel Disease WASHINGTON, Oct. 15 /PRNewswire-FirstCall/ -- Volcano Corporation today announced the launch of the PrimeWireTM Pressure Guidewire, and the s5-FFR Option for its existing installed base of s5 and s5i imaging...

  Articles 2008-10-15

• Volcano Corporation Announces Schedule of Events for TCT 2008

  Live Case Transmissions and Symposia to Highlight New Product Launches and Clinical Utility of Volcano Technologies including FFR, IVUS, VH IVUS, OCT and Forward-Looking IVUS WASHINGTON, Oct. 13 /PRNewswire-FirstCall/ -- Volcano Corporation today announced its participation in the 2008 TCT Conference in Washington, D.C. from October...

  Articles 2008-10-13

• Volcano Corporation Announces the Relocation of Corporate Headquarters to San Diego

  SAN DIEGO, Oct. 6 /PRNewswire-FirstCall/ -- Volcano Corporation , a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, today announced the relocation of its corporate headquarters from Northern California's Rancho Cordova to San Diego. The new corporate...

  Articles 2008-10-06

• Volcano Announces Resignation of Olav Bergheim from Board of Directors

  SAN DIEGO, Sept. 15 /PRNewswire-FirstCall/ -- Volcano Corporation , a leading manufacturer of intravascular ultrasound IVUS and functional measurement FM technology, announced today that Olav B. Bergheim, the company's chairman of the board, will resign from the board of directors effective as of the close of business on January...

  Articles 2008-09-15

• Volcano's VH® IVUS Technology Used in Imaging Study of GlaxoSmithKline's Novel Investigational Compound, Darapladib

  IBIS-2 Integrated Biomarker and Imaging Study Results Demonstrate Benefits of VHR IVUS in Drug Development SAN DIEGO, Calif., Sept. 2 /PRNewswire-FirstCall/ -- Volcano Corporation [ESC Booth # A2-D403], a leading manufacturer of intravascular ultrasound IVUS and functional measurement FM technology, announced today the use of its...

  Articles 2008-09-02

• VOLCANO HAS LAUNCHED ROTATIONAL IVUS/INTEGRATED FFR.(Disease/Disorder overview)

  Volcano Corporation (NASDAQ:VOLC), San Diego, Calif., a manufacturer and developer of intravascular ultrasound IVUS, functional measurement FM and Optical Coherence Tomography OCT products designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, has announced the U.S. and European launch of the...

  Articles 2008-05-01

• VOLCANOE REPORTS FDA 510(K)OF ROTATIONAL CATHETER/FFR.

  Volcano Corporation, San Diego, Calif., (NASDAQ:VOLC) a manufacturer of intravascular ultrasound IVUS and functional measurement FM technology, has announced FDA 510k clearance of the s5-Revo and s5-FFR fractional flow reserve options. These two new product offerings now enable rotational IVUS and FFR to operate on the...

  Articles 2008-03-01

• Wall Street News Alert: Aggressive Stock Alert: ELHI! February 14, 2008

  Wall Street News Alert's "stocks to watch" thismorning are: Edgeline Holdings, Inc. (OTCBB: ELHI), Abbott (NYSE: ABT),Gilead Sciences, Inc. (NASDAQ: GILD) and Volcano Corporation (NASDAQ: VOLC). Edgeline Holdings, Inc. (OTCBB: ELHI), which recently announced a namechange to Oncolin Therapeutics Inc., has issued more important news thatshould have investors attention this...

  Articles 2008-02-14

• Volcano Corporation Review in Progress.

  M2 PRESSWIRE-13 February 2008-The SI Report: Volcano Corporation Review in ProgressC1994-2008 M2 COMMUNICATIONS LTD RDATE:13022008 Streetinvesting.com has now resumed our progressive review of Volcano Corporation (Nasdaq: VOLC after it traded up10% Wednesday, early in the morning with above average...

  Articles 2008-02-13

• Perspective Review for Volcano Corporation.

  M2 PRESSWIRE-5 February 2008-Market Review: Perspective Review for Volcano CorporationC1994-2008 M2 COMMUNICATIONS LTD RDATE:06022008 Streetinvesting.com has now resumed our progressive review of Volcano Corporation (Nasdaq: VOLC) after it traded down 2% Tuesday, early in the afternoon with below average...

  Articles 2008-02-05

• JAPAN APPROVES VOLCANO'S S5I INTEGRATED IVUS SYSTEM.

  Volcano Corporation (NASDAQ:VOLC) has announced approval of the s5i Integrated IVUS System by necessary regulatory authorities in Japan, granting entry into the Japanese market. Volcano expects to launch the s5i into Japan, which represents the largest Intravascular Ultrasound IVUS market worldwide, during the current quarter. Volcano...

  Articles 2007-09-01

• Volcano Corporation is Added to the Bellwether Watch list.

  M2 PRESSWIRE-17 April 2007-Biotech News: Volcano Corporation is Added to the Bellwether Watch listC1994-2007 M2 COMMUNICATIONS LTD RDATE:17042007 Volcano Corporation (NASDAQ:VOLC) is Added to the Bellwether Watch list Volcano Corporation offers a broad suite of devices designed to ...

  Articles 2007-04-17

• Research and Markets: 35.8% of Fukuda Denshi Revenue Was Generated from the Sale of Medical Treatment Equipment

  DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c50873) has announced the addition of the Espicom Business Intelligence Ltd report: "Fukuda Denshi Medical Device Company Intelligence Report" to their offering. Fukuda Denshi, headquartered in Tokyo, Japan, develops, manufactures and markets medical electronic equipment, especially products related to the cardiovascular and...

  Articles 2007-02-21